Etiology and emerging treatments for familial chylomicronemia syndrome.
Catherine M SpagnuoloRobert A HegelePublished in: Expert review of endocrinology & metabolism (2024)
Apo C-III inhibitors currently in development are promising treatments for FCS.
Keyphrases